- Home
- RAPT vs PML Comparison
RAPT vs PML Comparison
Compare RAPT & PML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RAPT | PML |
|---|---|---|
| Founded | 2015 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 498.4M | 508.0M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | RAPT | PML |
|---|---|---|
| Price | $35.21 | $7.67 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $57.00 | N/A |
| AVG Volume (30 Days) | ★ 365.9K | 188.0K |
| Earning Date | 03-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.65% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.67 | $6.92 |
| 52 Week High | $42.39 | $9.46 |
Technical Indicators
Market Signals| Indicator | RAPT | PML |
|---|---|---|
| Relative Strength Index (RSI) | 55.37 | 57.36 |
| Support Level | $33.01 | $7.61 |
| Resistance Level | $35.42 | $7.64 |
| Average True Range (ATR) | 2.17 | 0.05 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 83.95 | 97.22 |
Price Performance
Historical ComparisonAbout RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About PML Pimco Municipal Income Fund II of Beneficial Interest
PIMCO Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal income tax. The fund portfolio of investments consists of investments in different sectors such as education, healthcare, and others.